Related Experiment Video
Updated: Aug 6, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Range-compensated pencil beam scanning proton Arc therapy: a feasibility study
Blake R Smith1, Ryan T Flynn2, Alonso N Gutiérrez3
1Department of Radiation Oncology, University of Iowa Health Care, Iowa City, IA, 52242, USA. blake-smith@uiowa.edu.
Abstract:
Proton arc therapy is a conceptual treatment technique in proton therapy that delivers a scanned proton pencil beam simultaneously as the gantry is rotated around the patient, exploiting the geometric advantages of a continuous arc with the dosimetric advantages of protons to maximize healthy tissue sparing. Here we propose an alternative approach to deliver pencil beam scanning (PBS) proton arc therapy using a beam-modifying device called a SpeleoFilter. SpeleoFilters can improve the treatment efficiency of proton arc by reducing the number of beam energies and beam spots while preserving the plan quality as compared to traditional multifield intensity modulated proton therapy (IMPT). The proposed SpeleoFilter framework was validated within a state-of-the art PBS collimator and IBA Dedicated Nozzle PBS system at the Miami Cancer Institute. The Monte Carlo methods developed in this work showed great agreement with experimental measurements and matched depth dose profiles within a 1-2%/1 mm gamma criteria. Proton arc treatments utilizing a SpeoleFilter resulted in comparable healthy tissue sparing and an order-of-magnitude reduction in the number of energy layers compared to IMPT for both phantom and patient datasets. Further work is necessary to fully demonstrate its application and clinical integration for multiple treatment sites.
More Related Videos
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022